These results not only provided evidence for a novel mechanism that regulated HB progression, but also suggested that the aggressive nature of HB was due, at least in part, to interactions between GATA4, miR125b, and the oncogenic gene DKK3. This evidence concerns the gene DKK3 and hemoglobin measurement.